Product Name | NebuSelect™ Recombinant Human Her2/ErbB2, Avi-His-tag |
---|---|
Catalog Number | NBL-240735 |
Alias/Synonyms | Her2/ErbB2; CD340; EGFR2; ErbB2; HER2; HER-2; herstatin; MLN 19; MLN19; Neu Oncogene; NEUHER-2/neu; NGL; p185erbB2; TKR1; ERBB2; HER-2/neu; NEU; ENV; ENVW; ERVWE1; HERV-7q; HERV-W-ENV; HERV7Q; HERVW; |
Appearance | see COA |
Molecule Weight | Thr23-Thr652 |
CAS | N/A |
Solubility | Water Soluble |
Storage | Short term 4℃; Long term -20℃. |
Shelf Life | 2 years |
Additional info 1 | P04626-1 |
Additional info 2 |
Catalog Numbe | Size | Price | Inventory Level | |
NBL-240735-100ug | 100ug | Inquire | Inquire | |
NBL-240735-1mg | 1mg | Inquire | Inquire | |
NBL-240735-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human Her2/ErbB2, Avi-His-tag
Catalog#:
NBL-240735
Description:
NebuSelect™ Recombinant Human Her2/ErbB2, Avi-His-tag(Cat#NBL-240735) is expressed in HEK293 with His tag and Avi tag at the C-Terminus.It contains Thr23-Thr652.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 72.3 kDa. Due to glycosylation, the protein migrates to 80-100 kDa based on Bis-Tris PAGE result.
Target Name:
Her2/ErbB2; CD340; EGFR2; ErbB2; HER2; HER-2; herstatin; MLN 19; MLN19; Neu Oncogene; NEUHER-2/neu; NGL; p185erbB2; TKR1; ERBB2; HER-2/neu; NEU; ENV; ENVW; ERVWE1; HERV-7q; HERV-W-ENV; HERV7Q; HERVW; HERVWENV
Target Information:
ErbB2, also called Neu and Her2 (human epidermal growth factor receptor 2), is a type I membrane glycoprotein that is a member of the ErbB family of tyrosine kinase receptors. ErbB family members serve as receptors for the epidermal growth factor (EGF) family of growth factors.Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane.
Amino Acid Sequence:
Thr23-Thr652
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.